1. A-582941, cholinergic alpha 7 nicotinic receptor agonist, improved cognitive and negative symptoms of the sub-chronic MK-801 model of schizophrenia in rats. Issue 1 (2nd January 2018) Authors: Unal, Gokhan; Aricioglu, Feyza Journal: Psychiatry and clinical psychopharmacology Issue: Volume 28:Issue 1(2018) Page Start: 4 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
2. Agmatine-attenuated cognitive and social deficits in subchronic MK-801 model of schizophrenia in rats. Issue 3 (3rd July 2018) Authors: Unal, Gokhan; Ates, Alpay; Aricioglu, Feyza Journal: Psychiatry and clinical psychopharmacology Issue: Volume 28:Issue 3(2018) Page Start: 245 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
3. Famotidine has a neuroprotective effect on MK-801 induced toxicity via the Akt/GSK-3β/β-catenin signaling pathway in the SH-SY5Y cell line. (1st December 2019) Authors: Unal, Gokhan; Dokumaci, Alim Hüseyin; Ozkartal, Ceren Sahin; Yerer, Mukerrem Betul; Aricioglu, Feyza Journal: Chemico-biological interactions Issue: Volume 314(2019) Page Start: Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
4. Immunopharmacological management of COVID-19: Potential therapeutic role of valproic acid. (October 2020) Authors: Unal, Gokhan; Turan, Bahadir; Balcioglu, Yasin Hasan Journal: Medical hypotheses Issue: Volume 143(2020) Page Start: Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
5. Neuroinflammation in Schizophrenia: A Critical Review and The Future. Issue 4 (1st December 2016) Authors: Aricioglu, Feyza; Ozkartal, Ceren Sahin; Unal, Gokhan; Dursun, Serdar; Cetin, Mesut; Müller, Norbert Journal: Klinik psikofarmakoloji bülteni = Issue: Volume 26:Issue 4(2016) Page Start: 429 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
6. Oral Research Presentations. (30th April 2018) Authors: Gürbüz, Hatice Gözde Akkın; Turhan, Levent; Şendil, Nilgun; Kaşıkçı, Halim Ömer; Salepçi, Banu; Ipekcioglu, Derya; Karcı, Canan Kuygun; Ray, Perihan Çam; Tahiroğlu, Ayşegül Yolga; Avcı, Ayşe; Çelik, Gonca Gül; Cekin, Necmi; Evliyaoğlu, Nurdan; Alkanat, Mehmet; Özdemir, Hafize; Akgün, Egemen; Demi... Journal: Psychiatry and clinical psychopharmacology Issue: Volume 28(2018)Supplement 1 Page Start: 1 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
7. Outstanding Awards Brief Reports. (30th April 2018) Authors: Ardic, Ferhat Can; Kose, Samet; Solmaz, Mustafa; Kulacaoglu, Filiz; Balcioglu, Yasin Hasan; Yıldız, Emrah; Elboğa, Gülçin; Altındağ, Abdurrahman; Arslan, Mehmet; Metehan Çalışkan, Ali; Göktaş, Duygu; İnanlı, İkbal; Çalışır, Saliha; Eren, İbrahim; Unal, Gokhan; Aricioglu, Feyza; Yulaf, Yasemin; Gü... Journal: Psychiatry and clinical psychopharmacology Issue: Volume 28(2018)Supplement 1 Page Start: 271 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
8. Vortioxetine suppresses epileptiform activity and cognition deficits in a chronic PTZ‐induced kindling rat model. Issue 6 (7th January 2022) Authors: Taskiran, Mehmet; Unal, Gokhan Journal: Epileptic disorders Issue: Volume 23:Issue 6(2021) Page Start: 893 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗